Showing results (111-120 of 771) with videos related to
Sort By:
Pageof 78
AIDS (London, England)|August 18, 2009
HIV-infected persons continue to lose kidney function despite successful antiretroviral therapyAndy I Choi, Michael G Shlipak, Peter W Hunt, et al.AIDS Research and Human Retroviruses|August 23, 2011
Immune activation in the pathogenesis of treated chronic HIV disease: a workshop summarySusan F Plaeger, Brenda S Collins, Runa Musib, et al.Human Immunology|January 4, 2012
Epistatic interactions between Fc (GM) and FcγR genes and the host control of human immunodeficiency virus replicationRaymond N Deepe, Emily Kistner-Griffin, Jeffrey N Martin, et al.Antiviral Therapy|June 9, 2006
A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtideGeorge Beatty, Peter Hunt, Anna Smith, et al.Plos One|April 18, 2014
Regulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirsBasile Siewe, Jennillee Wallace, Sonya Rygielski, et al.Plos Pathogens|January 16, 2019
Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latencyZichong Li, Jun Wu, Leonard Chavez, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2012
The activity of the integrase inhibitor dolutegravir against HIV-1 variants isolated from raltegravir-treated adultsMark R Underwood, Brian A Johns, Akihiko Sato, et al.AIDS (London, England)|April 26, 2011
Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected personsAndy I Choi, Eric Vittinghoff, Steven G Deeks, et al.The Journal of Infectious Diseases|September 27, 2003
Assessing resistance costs of antiretroviral therapies via measures of future drug optionsHongyu Jiang, Steven G Deeks, Daniel R Kuritzkes, et al.Circulation|January 27, 2010
Association between kidney function and albuminuria with cardiovascular events in HIV-infected personsAndy I Choi, Yongmei Li, Steven G Deeks, et al.Pageof 78